CN1879722A - A medicine for treating rheumatic arthritis - Google Patents

A medicine for treating rheumatic arthritis Download PDF

Info

Publication number
CN1879722A
CN1879722A CN 200610080014 CN200610080014A CN1879722A CN 1879722 A CN1879722 A CN 1879722A CN 200610080014 CN200610080014 CN 200610080014 CN 200610080014 A CN200610080014 A CN 200610080014A CN 1879722 A CN1879722 A CN 1879722A
Authority
CN
China
Prior art keywords
weight portion
weight
radix
medicine
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200610080014
Other languages
Chinese (zh)
Inventor
赵玉才
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200610080014 priority Critical patent/CN1879722A/en
Publication of CN1879722A publication Critical patent/CN1879722A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating rheumatic arthritis which is prepared from the following constituents (by weight ratio): Chinese angelica root 5-25, pubescent angelica root 5-20, Loranthus mulberry mistletoe 5-20, gentiana macrophylla pall 5-20, asarum herb 2-10, red peony root 5-20, eucommia bark 5-20, cinnamon twig 2-10, dipsacus root 5-20, pawpaw 5-20.

Description

A kind of medicine for the treatment of rheumatic arthritis
Affiliated technical field
The present invention relates to a kind of Chinese medicine, relating to a kind of specifically is the medicine of raw material treatment rheumatic arthritis with the Chinese herbal medicine.
Background technology
Rheumatism is a kind of pathological changes systemic disease widely, and it can a plurality of systems be got involved, and especially moves, circulation and nervous system be for main.The rheumatic arthritis onset is hurried, mainly show as the polyarthritis of migration, normal symmetry is involved big joint such as knee joint, ankle, shoulder, elbow, hip, mainly showing as local joint has significantly red, swollen, hot, pain and touches a tender spot, and painful migratory pain is migration, promptly behind the joint sx of original invasion and attack, other joints begin to occur symptom again, rise one after another, repeatedly outbreak.Symptom is fixed on about 1272 hours of the time in a joint, and the persistent period was no more than for 3 weeks at most.Simultaneously, the position of arthralgia sometimes also can be with cutaneous annular erythema or subcutaneous nodule.Loss of appetite, fatigue and weak, or fever is arranged, tongue is greasy in vain or light fish is greasy, light red tongue, slippery and rapid pulse.Just because of this, therefrom hospital's face is said, arthritis belongs to " arthromyodynia ".
Etiology and pathology: " wet three gas of wind and cold are assorted extremely, close and be numbness ", wet three heresies of wind and cold are arthromyodynia main causes, but children's is in the majority with heat symptom-complex, and arthromyodynia is no exception, because children's is a pure-yang constituent, wind and cold is easy to heat-transformation, so show as " rheumatism pyretic arthralgia " clinically, it is scorchingly hot mainly to show as rheumatism more.
Summary of the invention
The object of the present invention is to provide a kind of antiinflammatory effective, short treating period, painful little, be free from side effects, to the undamaged a kind of medicine for the treatment of rheumatic arthritis of health.
Medicine of the present invention be the inventor based on motherland's medical science to the pathogenetic understanding of rheumatic arthritis, in line with diffusing wind heat clearing away, the principle of dampness removing collateral dredging, through clinical trial for many years, checking draws repeatedly.
Medicine of the present invention is made (consumption is a weight portion) by following component
Radix Angelicae Sinensis 5-25, Radix Angelicae Pubescentis 5-20, parasitic 5-20, Radix Gentianae Macrophyllae 5-20, Herba Asari 2-10, Radix Paeoniae Rubra 5-20, Cortex Eucommiae 5-20, Ramulus Cinnamomi 2-10, Radix Dipsaci 5-20, Fructus Chaenomelis 5-20.
Preferred weight part of medicine of the present invention is:
Radix Angelicae Sinensis 10-20, Radix Angelicae Pubescentis 6-15, parasitic 8-15, Radix Gentianae Macrophyllae 8-15, Herba Asari 2-5, Radix Paeoniae Rubra 8-15, Cortex Eucommiae 8-15, Ramulus Cinnamomi 2-8, Radix Dipsaci 8-15, Fructus Chaenomelis 8-15.
Optimum weight part of medicine of the present invention is:
Radix Angelicae Sinensis 15, Radix Angelicae Pubescentis 10, parasitism 10, Radix Gentianae Macrophyllae 10, Herba Asari 3, Radix Paeoniae Rubra 10, the Cortex Eucommiae 10, Ramulus Cinnamomi 5, Radix Dipsaci 10, Fructus Chaenomelis 10.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any routine dosage form for oral administration, for example these crude drug pulverize mix homogeneously can be made powder and take after mixing it with water; These crude drug decoctings can be made decoction oral; Also can directly make the honeyed pill or the watered pill etc. with adding adjuvant after the raw material pulverizing.In order to make each crude drug better bring into play curative effect, preferably the crude drug decocting is made decoction oral.
The instructions of taking of medicine of the present invention, medicine of the present invention general every day of potion divides secondary oral, and 7 days is a course of treatment.
Beneficial effect of the present invention is: drug regimen of the present invention makes each medicine produce synergism, effectively rheumatic arthritis.Arthralgia, not red pneumonedema does not heal for a long time, or the time end when sending out, or joint joint stuffiness, waist lower limb weakness, tired easily tired, the complexion HUANGBAI(sic), tongue is white, light red tongue is white, stringy and thready pulse.This kind of belongs to chronic rheumatic arthritis, " prolonged illness must empty ", so sick beginning to the transition of deficient syndrome sympotoms caused by cold factors, treatment is just with eliminating evil and just double the executing of Gu.Radix Angelicae Pubescentis, Fructus Chaenomelis, the diffusing wind damp eliminating of Radix Gentianae Macrophyllae in the side, Herba Asari, Ramulus Cinnamomi warming YANG to expel cold, Radix Paeoniae Rubra, Chinese Angelica blood replonishing are invigorated blood circulation, parasitism, the Cortex Eucommiae, the strong muscles and bones of Radix Dipsaci the kidney invigorating.
Taboo: living, peppery, cold food reaches cigarette, wine.
Clinical observation of the present invention:
1, physical data
Accept patient's totally 126 examples for medical treatment, wherein male 59 examples, women 67 examples, age 25-68 year.
2, diagnostic criteria
That local joint has is significantly red, swollen, hot, pain and touching a tender spot, and painful migratory pain is migration, and simultaneously, the position of arthralgia sometimes also can be with cutaneous annular erythema or subcutaneous nodule.The patient has loss of appetite, fatigue and weak, or fever is arranged, tongue is greasy in vain or light fish is greasy, light red tongue, slippery and rapid pulse.
3, Therapeutic Method
General every day, potion divided secondary oral, and 7 days is a course of treatment.
4, efficacy assessment standard
Produce effects: the symptom complete obiteration, functional rehabilitation is normal, and laboratory indexes is normal.
Take a turn for the better: symptom is obviously alleviated, and function makes moderate progress, and laboratory indexes takes a turn for the better.
Invalid: as not reach the improvement standard.
5, therapeutic outcome
Produce effects Take a turn for the better Invalid Effective percentage %
The example number Obvious effective rate % The example number Improvement rate % The example number Inefficiency %
108 85.71 15 11.9 3 2.38 97.62
The specific embodiment
[embodiment 1]
Take by weighing raw material by following proportioning: Radix Angelicae Sinensis 15 grams, Radix Angelicae Pubescentis 10 grams, parasitic 10 grams, Radix Gentianae Macrophyllae 10 grams, Herba Asari 3 grams, Radix Paeoniae Rubra 10 grams, the Cortex Eucommiae 10 grams, Ramulus Cinnamomi 5 grams, Radix Dipsaci 10 grams, Fructus Chaenomelis 10 grams.The crude drug decocting is made decoction oral.
[embodiment 2]
Take by weighing raw material by following proportioning: Radix Angelicae Sinensis 10 grams, Radix Angelicae Pubescentis 6 grams, parasitic 8 grams, Radix Gentianae Macrophyllae 8 grams, Herba Asari 2 grams, Radix Paeoniae Rubra 8 grams, the Cortex Eucommiae 8 grams, Ramulus Cinnamomi 2 grams, Radix Dipsaci 8 grams, Fructus Chaenomelis 8 grams.The crude drug decocting is made decoction oral.
[embodiment 3]
Take by weighing raw material by following proportioning: Radix Angelicae Sinensis 20 grams, Radix Angelicae Pubescentis 15 grams, parasitic 15 grams, Radix Gentianae Macrophyllae 15 grams, Herba Asari 5 grams, Radix Paeoniae Rubra 15 grams, the Cortex Eucommiae 15 grams, Ramulus Cinnamomi 8 grams, Radix Dipsaci 15 grams, Fructus Chaenomelis 15 grams.The crude drug decocting is made decoction oral.

Claims (3)

1, a kind of medicine for the treatment of rheumatic arthritis is characterized in that: it is the medicament of being made by the following weight proportion raw material:
Radix Angelicae Sinensis 5-25 weight portion, Radix Angelicae Pubescentis 5-20 weight portion, parasitic 5-20 weight portion, Radix Gentianae Macrophyllae 5-20 weight portion, Herba Asari 2-10 weight portion, Radix Paeoniae Rubra 5-20 weight portion, Cortex Eucommiae 5-20 weight portion, Ramulus Cinnamomi 2-10 weight portion, Radix Dipsaci 5-20 weight portion, Fructus Chaenomelis 5-20 weight portion.
2, the medicine of treatment rheumatic arthritis according to claim 1 is characterized in that: wherein the weight proportion of each crude drug is:
Radix Angelicae Sinensis 10-20 weight portion, Radix Angelicae Pubescentis 6-15 weight portion, parasitic 8-15 weight portion, Radix Gentianae Macrophyllae 8-15 weight portion, Herba Asari 2-5 weight portion, Radix Paeoniae Rubra 8-15 weight portion, Cortex Eucommiae 8-15 weight portion, Ramulus Cinnamomi 2-8 weight portion, Radix Dipsaci 8-15 weight portion, Fructus Chaenomelis 8-15 weight portion.
3, the medicine of treatment rheumatic arthritis according to claim 1 is characterized in that: wherein the weight proportion of each crude drug is:
Radix Angelicae Sinensis 15 weight portions, Radix Angelicae Pubescentis 10 weight portions, parasitic 10 weight portions, Radix Gentianae Macrophyllae 10 weight portions, Herba Asari 3 weight portions, Radix Paeoniae Rubra 10 weight portions, the Cortex Eucommiae 10 weight portions, Ramulus Cinnamomi 5 weight portions, Radix Dipsaci 10 weight portions, Fructus Chaenomelis 10 weight portions.
CN 200610080014 2006-04-29 2006-04-29 A medicine for treating rheumatic arthritis Pending CN1879722A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200610080014 CN1879722A (en) 2006-04-29 2006-04-29 A medicine for treating rheumatic arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200610080014 CN1879722A (en) 2006-04-29 2006-04-29 A medicine for treating rheumatic arthritis

Publications (1)

Publication Number Publication Date
CN1879722A true CN1879722A (en) 2006-12-20

Family

ID=37518223

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200610080014 Pending CN1879722A (en) 2006-04-29 2006-04-29 A medicine for treating rheumatic arthritis

Country Status (1)

Country Link
CN (1) CN1879722A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104644868A (en) * 2015-03-23 2015-05-27 曹燕欣 Traditional Chinese medicine composition for treating arthritis caused by rheumatic fever and preparation method of traditional Chinese medicine composition
CN105902797A (en) * 2016-06-30 2016-08-31 田引娣 Medicine for treating rheumatic arthritis
CN107648440A (en) * 2017-09-20 2018-02-02 佛山市秸和科技有限公司 A kind of Chinese medicine for being used to treat rheumatic arthritis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104644868A (en) * 2015-03-23 2015-05-27 曹燕欣 Traditional Chinese medicine composition for treating arthritis caused by rheumatic fever and preparation method of traditional Chinese medicine composition
CN105902797A (en) * 2016-06-30 2016-08-31 田引娣 Medicine for treating rheumatic arthritis
CN107648440A (en) * 2017-09-20 2018-02-02 佛山市秸和科技有限公司 A kind of Chinese medicine for being used to treat rheumatic arthritis

Similar Documents

Publication Publication Date Title
CN102940853B (en) Navel paste for treating mammary gland hyperplasia diseases
CN101062372A (en) Chinese herbal medicine preparation for dissolving hepatobiliary system calculi
CN101406688B (en) Compound formulation for treating rheumatic arthritis and rheumatoid arthritis
CN1879852A (en) A gall stone-treating medicine
CN105381132A (en) Drug for treating thyroid nodule
CN101912536B (en) Medicinal composition for treating rheumatism and rheumatoid disease
CN1879722A (en) A medicine for treating rheumatic arthritis
CN1054528C (en) Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin"
CN1389255A (en) Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis
CN100460005C (en) Medicine composition for treating rheumatism and rheumatoid arthritis
CN103230566B (en) Traditional Chinese medical composition for treating cholecystitis cholelithiasis and application thereof
CN104491459A (en) Traditional Chinese medicine composition for treating tumors
CN103705846A (en) Traditional Chinese medicine preparation for treating ovarian cyst
CN105012924B (en) A kind of externally applied drug for treating rheumatism
CN1186044C (en) Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis
CN102727811B (en) Pharmaceutical composition for treating rheumatoid arthritis
CN105362382A (en) Traditional Chinese medicine composition for treating recurrent oral ulcer and application thereof
CN100427132C (en) Traditional Chinese medicine for treating rheumatism and its preparing process
CN103933277A (en) Tibetan drug for treating gout disease
CN102274336B (en) Medicine composition for treating rheumatoid arthritis
CN1745839A (en) Compound Chinese medicine for gout
CN102389545A (en) Traditional Chinese medicine for treating diabetic gout
CN102258589B (en) Deer blood medicinal wine for treating rheumatoid arthritis
CN101361934B (en) Traditional Chinese medicine preparation for treating arthritis and various osteonosus
CN102228661B (en) Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned